Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842540 · ClinicalTrials.gov registry record · NA
The Share Health Study: Teen Social Connections and Health (Phase 2)
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,099
- Enrollment target
NCT03842540 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,099 participants.
The verdict
NCT03842540, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,099 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether delivery of SpeakOut, a behavioral intervention to increase social communication about long-acting reversible contraceptive (LARC) methods among adolescents, is associated with increased contraceptive use among the social contacts of SpeakOut recipients. The investigators will conduct a cluster randomized controlled trial of SpeakOut with adolescent LARC users and their female peers. Over three years, SpeakOut will be implemented in eight partner clinics. IUD and implant users aged 15 to 19 will be recruited online and invited to enroll in the evaluation study as "primary" participants and receive either SpeakOut or a control intervention about alcohol use called PartyWise. The social contacts of primary participants will be asked to enroll in the study as "secondary" participants. The study's primary outcome will be the proportion of sexually-active secondary participants who are using any contraceptive method at 9-month follow-up.
Interventions
- BEHAVIORAL SpeakOut
- BEHAVIORAL PartyWise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,099 participants |
| Start Date | 2019-02-05 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03842540
The ClinicalTrials.gov registry entry for NCT03842540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,099 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SpeakOut is the first listed.
NCT03842540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03842540 about?
NCT03842540 is a clinical study titled "The Share Health Study: Teen Social Connections and Health (Phase 2)". The purpose of this study is to determine whether delivery of SpeakOut, a behavioral intervention to increase social communication about long-acting reversible contraceptive (LARC) methods among adolescents, is associated with increased contraceptive use among the social contacts of SpeakOut recipie...
What is the current status of trial NCT03842540?
This trial is currently completed. It is a NA study. The enrollment target is 1,099 participants. The study started on 2019-02-05. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03842540?
The interventions under investigation include: SpeakOut (BEHAVIORAL), PartyWise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03842540?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.